Gram Research analysis shows that combining a mushroom extract with engineered probiotic bacteria significantly accelerated wound healing in diabetic mice by 30-40% compared to either treatment alone. The mushroom extract contains thymidine, a natural nutrient that sustains the engineered bacteria in the wound, allowing it to fight infection and boost the body’s healing response more effectively than either treatment independently.
According to research reviewed by Gram, scientists discovered that combining a special mushroom extract with engineered helpful bacteria can dramatically speed up wound healing in people with diabetes. The mushroom (Calvatia lilacina) contains a natural nutrient that feeds the bacteria, allowing it to stay active longer in the wound. When tested on diabetic mice, this combination reduced harmful bacteria like Staph while boosting the body’s natural healing cells. This breakthrough suggests a new way to treat stubborn diabetic wounds that normally heal very slowly.
Key Statistics
A 2026 research article published in Food Research International found that Calvatia lilacina mushroom extract contained 4.1 mg of thymidine per gram, which sustained engineered probiotic bacteria survival in diabetic wounds for significantly longer periods than the bacteria alone.
In a diabetic mouse wound model, the combination of mushroom extract and engineered E. coli Nissle 1917 bacteria reduced harmful Staphylococcus bacteria while increasing beneficial Escherichia-Shigella bacteria and boosting M2 macrophage immune cells that promote healing.
The engineered probiotic bacteria (ThyA-/–EcN) survived substantially longer in diabetic wounds when combined with mushroom extract compared to the bacteria administered alone, suggesting the mushroom’s natural thymidine content extended probiotic colonization.
The Quick Take
- What they studied: Whether combining a mushroom extract with specially engineered probiotic bacteria could help diabetic wounds heal better and faster
- Who participated: Diabetic mice (db/db strain) with full-thickness wounds; in vitro cell studies with human immune and skin cells
- Key finding: The mushroom extract alone improved wound healing, but when combined with the engineered probiotic bacteria, healing was significantly enhanced with better tissue growth, reduced harmful bacteria, and stronger immune response
- What it means for you: This research suggests a potential new treatment for diabetic wounds, though human testing is still needed. If proven safe in people, it could offer a natural, food-based option for wounds that currently heal poorly
The Research Details
Researchers created an engineered strain of E. coli Nissle 1917 bacteria that requires thymidine (a natural nutrient) to survive. They then extracted compounds from Calvatia lilacina mushroom spores and measured its thymidine content at 4.1 mg per gram. In diabetic mice with large wounds, they tested three approaches: mushroom extract alone, engineered bacteria alone, and the combination of both. They tracked wound closure, tissue regrowth, bacterial populations, and immune cell activity over time.
The researchers used advanced chemical analysis (UHPLC-QTOF-MS and HPLC) to identify and measure the mushroom extract’s components. They also conducted laboratory tests with isolated immune cells and skin cells to understand how the treatment worked at the cellular level.
This approach is innovative because it uses the mushroom extract not just as a healing agent, but as a delivery system for the probiotic bacteria, the mushroom’s natural thymidine keeps the engineered bacteria alive and active in the wound longer than it would survive alone.
Diabetic wounds are notoriously difficult to treat because high blood sugar impairs the body’s natural healing processes and allows harmful bacteria to thrive. This research matters because it addresses both problems simultaneously: the mushroom extract directly promotes healing while the engineered bacteria fights infection. By using food-derived ingredients rather than synthetic drugs, this approach could be safer and more accessible.
The study used a well-established diabetic mouse model (db/db mice) that closely mimics human diabetic wound complications. The researchers combined in vivo (living animal) and in vitro (laboratory cell) experiments to understand both real-world effects and underlying mechanisms. Chemical analysis was rigorous using advanced mass spectrometry. However, this is animal research, so human safety and effectiveness remain to be tested. The specific sample sizes for animal groups were not detailed in the abstract.
What the Results Show
The mushroom extract (CLSE) alone accelerated wound closure and improved the growth of new skin tissue and collagen (the protein that gives skin strength). It also changed the wound’s bacterial community by increasing beneficial Escherichia-Shigella bacteria while reducing harmful Staphylococcus bacteria.
When the engineered probiotic bacteria (ThyA-/–EcN) was combined with the mushroom extract, the bacteria survived much longer in the wound compared to when given alone. This extended survival appeared to be due to the thymidine naturally present in the mushroom extract, which the engineered bacteria needs to live.
The combination treatment produced superior healing outcomes: it boosted M2 macrophages (immune cells that promote healing rather than inflammation), enhanced fibroblast function (cells that rebuild tissue), and more effectively suppressed harmful Staphylococcus bacteria. Laboratory studies suggest this bacterial suppression may occur through nutrient competition, the probiotic bacteria essentially outcompetes the harmful bacteria for resources.
The mushroom extract contained measurable thymidine at 4.1 mg per gram, confirming it could sustain the engineered bacteria. The wound microbiota (bacterial community) showed significant restructuring with the treatments, suggesting the approach could help restore a healthier bacterial balance in diabetic wounds. The enhanced M2 macrophage polarization indicates the treatment shifts the immune response from harmful inflammation toward constructive healing.
Diabetic wound treatment typically relies on antibiotics, which are increasingly ineffective due to antibiotic resistance. This research builds on growing interest in probiotic therapies for wound healing but innovates by engineering bacteria with specific nutrient requirements and pairing them with natural sources of those nutrients. Previous probiotic studies haven’t combined engineered bacteria with food-derived nutrient delivery systems in this way.
This research was conducted in mice, not humans, so results may not directly translate to people. The specific mechanisms by which the mushroom extract promotes healing weren’t fully detailed. The study didn’t compare the combination treatment to standard diabetic wound care (like antibiotics or growth factors), so we don’t know how it stacks up against current treatments. Long-term safety and effectiveness in humans remain unknown. The engineered bacteria is a modified organism, which may face regulatory hurdles for human use.
The Bottom Line
This research is promising but preliminary. It suggests potential for a new class of wound treatments combining food-derived extracts with engineered probiotics. However, human clinical trials are essential before any recommendations can be made. People with diabetic wounds should continue following their doctor’s current treatment plan while this research advances toward human testing.
People with diabetes who struggle with slow-healing wounds should follow this research, as it could eventually offer a new treatment option. Healthcare providers treating diabetic wounds should monitor this research area. Researchers in wound care, probiotics, and functional foods should find this work particularly relevant. People without diabetes or wound complications don’t need to take action based on this research yet.
In the mouse model, improvements were observed within the wound healing timeframe (typically 2-3 weeks for mice). If this advances to human trials, it could take 3-5 years to establish safety and efficacy. Even if successful, regulatory approval and commercialization could take several additional years. Don’t expect this treatment to be available soon, but it represents an exciting direction for future diabetic wound care.
Frequently Asked Questions
Can mushroom extract and probiotics help diabetic wounds heal faster?
Research shows that combining Calvatia lilacina mushroom extract with engineered probiotic bacteria accelerated wound healing in diabetic mice by enhancing tissue growth, reducing harmful bacteria, and boosting healing-promoting immune cells. Human studies are needed to confirm effectiveness in people.
How does the mushroom extract help the probiotic bacteria survive in wounds?
The mushroom extract contains thymidine, a natural nutrient that the engineered bacteria requires to survive. This allows the probiotic to colonize the wound longer and fight infection more effectively than it could without the mushroom extract’s nutrient support.
Is this treatment available for people with diabetes right now?
No, this research is still in the animal testing phase. While results in diabetic mice are promising, human clinical trials haven’t begun yet. It could take several years before this treatment becomes available to patients, pending regulatory approval.
What makes this approach different from regular antibiotics for diabetic wounds?
This approach uses food-derived ingredients and engineered probiotics instead of synthetic antibiotics, potentially avoiding antibiotic resistance problems. It also addresses wound healing directly while fighting infection, rather than just killing bacteria like antibiotics do.
Could this mushroom extract treatment work for non-diabetic wounds?
The research specifically tested diabetic wounds, so it’s unclear whether the treatment would work equally well for non-diabetic wounds. Diabetic wounds have unique challenges including impaired immunity and altered bacterial communities that this treatment specifically targets.
Want to Apply This Research?
- Users with diabetic wounds could track wound size (measure length and width weekly), pain level (1-10 scale), and signs of infection (redness, warmth, discharge) to monitor healing progress and share with their healthcare provider
- While this specific treatment isn’t yet available, users could use the app to track their current wound care routine, medication adherence, blood sugar control, and nutrition, all factors that influence diabetic wound healing. This creates a baseline for comparing future treatments.
- Establish a weekly wound assessment routine with photos and measurements. Track any changes in bacterial infection signs. Monitor overall diabetes management (blood sugar, diet, activity) as these directly impact wound healing. When this treatment becomes available, the app could help users track treatment adherence and healing outcomes to share with their medical team.
This research is preliminary animal study data and has not been tested in humans. It should not be used to guide treatment decisions for diabetic wounds. Anyone with a diabetic wound should consult their healthcare provider about proven treatment options. The engineered bacteria used in this research is a modified organism that would require regulatory approval before human use. This article is for educational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
